Particulars |
Company Name |
Ipca Laboratories Ltd |
Year End |
2023/03 |
Full Year |
Equity (Rs Cr.) |
25.37 |
B.V (Rs) |
244.60 |
Sales (Rs Cr.) |
5,814.62 |
NP. (Rs Cr.) |
486.27 |
NP Var% |
-43.00 |
Div% |
400.00 |
CPS (Rs) |
28.20 |
EPS (Rs) |
19.20 |
Traded Value (Rs Lakhs) |
77.00 |
52 Week High |
1,374.00 |
52 Week Low |
670.00 |
Price BSE |
1,276.00 |
Price NSE |
1,276.00 |
Market Capital (Rs Cr.) |
32,375.20 |
P/C Ratio |
45.30 |
P/E Ratio |
66.60 |
Price Vs.BV |
5.22 |
|
Latest Quarter |
Year End |
202312 |
Sales (Rs Cr.) |
1,506.83 |
NP (Rs Cr.) |
136.94 |
NP Var % |
19.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
5,451.08 |
OPM |
18.71 |
NP |
640.18 |
NP Var% |
3.66 |
EPS |
21.70 |
PE |
58.81 |
|
|